Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 8
238
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Two new 8-isopentenyl isoflavane derivatives from Astragalus dolichochaete diels

, , , , &
Pages 1323-1330 | Received 30 Dec 2018, Accepted 14 Jul 2019, Published online: 30 Jul 2019
 

Abstract

Astragali Radix (Huangqi) is one of the well-known traditional Chinese medicines and has been used in China for more than two thousand years. As a close species, Astragalus dolichochaete Diels was found to possess cytotoxicity during our preliminary study of Astragalus plants from Yunnan Province, China. To better understand the chemical foundation of the cytotoxicity, the major constituents of A. dolichochaete were studied. As a result, two new 8-isopentenyl isoflavane derivatives, dolichochaeteins A and B (1 and 2), together with ten known constituents were isolated, and their structures were elucidated by means of spectroscopy, mainly 1D and 2D NMR techniques. The cytotoxic activities were evaluated for the raw extract, ethyl acetate fraction, compound 2 and glyasperin H (3) against human gastric carcinoma cell line SGC-7901, human hepatoma cell line SMMC-7721 and human leukemic cell line K562. All the samples exhibited significant cytotoxicity.

Graphical Abstract

Acknowledgements

The authors are grateful to Mr. Ling-Yun Jiang of The Library of Dali University for his kindly help with information retrieval. We thank Mr. Erich Grundel, a retired employee (Chemist) from FDA, USA, for manuscript revision.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The work was financially supported by the National Natural Science Foundation of China [grant numbers 31170313 and 81460532], and the Innovation Team Project of Dali University for Development and Utilization of Characteristic Medicinal Plants in Western Yunnan & Bai Nationality Medicines [grant number ZKLX2019106].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.